DMSA vs DTPA for Heavy Metal Chelation
DMSA is the preferred first-line chelating agent for lead, mercury, and arsenic poisoning due to its oral bioavailability, superior safety profile, and lower toxicity compared to other chelators, while Ca-DTPA is specifically indicated only for internal contamination with plutonium, americium, or curium.
Indications
DMSA (Dimercaptosuccinic Acid/Succimer)
- Primary indication: Lead poisoning 1, 2, 3
- Also effective for mercury and arsenic poisoning 1, 3
- Used for moderate to severe lead toxicity with blood lead levels requiring chelation 2
Ca-DTPA (Calcium-Diethylenetriamine-Pentaacetate)
- FDA-approved indication: Internal contamination with plutonium, americium, or curium ONLY 4
- Not effective for: Uranium, neptunium, or radioactive iodine 4
- May have utility in acute heavy metal poisoning with lead, cadmium, or mercury 5, though this is off-label
Key Pharmacologic Differences
Route of Administration
- DMSA: Oral administration with ~5% GI absorption 4, making it practical for outpatient management
- Ca-DTPA: Must be given intravenously or by inhalation; oral route ineffective 4
Distribution and Mechanism
- DMSA: Distributed extracellularly, extensively metabolized to cysteine mixed disulfides (likely the active chelating moiety), with chelation occurring primarily in the kidney 2
- Ca-DTPA: Rapidly distributed throughout extracellular fluid space, cleared by glomerular filtration unchanged, forms stable chelates by exchanging calcium for metals with greater binding capacity 4
Tissue Specificity for Lead
- DMSA: More effective at reducing kidney lead concentrations 2
- Ca-DTPA: More effective at mobilizing bone lead stores 2
- Neither significantly penetrates the blood-brain barrier 2
Dosing
DMSA
- Standard dose: 1050 mg/m²/day orally 6
- Typically given in divided doses over 5-day courses with 10-day rest periods between courses 6
- Multiple intermittent courses recommended for complete mobilization 1
Ca-DTPA
- Critical dosing limitation: Only a single initial dose of Ca-DTPA is recommended 4
- Standard dose: 1 gram IV or by inhalation 4
- After initial dose, must switch to Zn-DTPA if continued chelation needed 4
- If Zn-DTPA unavailable and Ca-DTPA continued, mandatory zinc supplementation required 4
Safety Profile and Toxicity
DMSA
- Considerably lower toxicity than classic chelators like BAL 1
- Less toxic than DMPS 1
- Depletes zinc and copper, but to a lesser degree than Ca-DTPA 2
- Transient hepatic transaminase elevation possible but rarely clinically significant 2
- Rare severe mucocutaneous reactions requiring discontinuation 2
Ca-DTPA
- Significant depletion of endogenous trace metals (zinc, magnesium, manganese) 4
- Magnitude of depletion increases with split daily dosing, higher doses, and longer duration 4
- Reduces serum alkaline phosphatase, LDH, and creatinine kinase activities 5
- Deaths reported in patients with severe hemochromatosis receiving excessive doses 4
- Caution required in hemochromatosis patients 4
- Nebulized administration may exacerbate asthma 4
- More potent for removing essential metals than Zn-DTPA 5
Clinical Efficacy Comparison
For Lead Poisoning
When comparing equimolar doses in adults:
- Ca-DTPA more effective at lead mobilization (p = 0.04) 6
- DMSA greater impact on reducing blood lead concentrations (p = 0.005) 6
- Both significantly reduce clinical symptoms and are well-tolerated 6
- However: Ca-DTPA's single-dose limitation and toxicity profile make DMSA the practical choice 4, 1
Timing Considerations
- Both agents: Effectiveness decreases with time after contamination 4, 7
- Chelation most effective within 24 hours of exposure 4
- DMSA given orally after oral exposure efficiently removes metal from GI tract 7
- Combined early treatment may be superior in some scenarios 7
Clinical Algorithm
For lead, mercury, or arsenic poisoning:
- Use DMSA as first-line agent 1, 2
- Administer orally in multiple courses with rest periods 6
- Monitor zinc and copper levels; supplement as needed 2
For plutonium, americium, or curium contamination:
- Give single dose of Ca-DTPA immediately 4
- Switch to Zn-DTPA for maintenance therapy 4
- Mandatory mineral supplementation if Ca-DTPA continued 4
- Avoid in severe hemochromatosis 4
Common Pitfall: Do NOT use multiple doses of Ca-DTPA without switching to Zn-DTPA or providing zinc supplementation—this causes severe trace metal depletion 4, 5.